Cooley Grows Life Sciences and Healthcare Regulatory Practice With Partner Hire

Washington, DC – April 15, 2025 – Eric Greig has joined Cooley’s Washington, DC, office as the newest partner in the firm’s global life sciences and healthcare regulatory practice. Greig advises clients on healthcare regulatory, market access and reimbursement strategies across the medical device, pharmaceutical, digital health, biotechnology, diagnostics and healthcare services sectors.

“Eric’s addition perfectly complements our market-leading practice of esteemed life sciences advisors,” said Sonya Erickson, Cooley partner and chair of the firm’s global business department. “With a track record of success in bet-the-company regulatory matters and deep knowledge of the drug and device reimbursement framework, Eric will be invaluable as we help our clients shape and respond to the laws and policies affecting their businesses.”

Greig joins from Latham & Watkins, where he most recently served as a partner in its healthcare and life sciences group. During his 15-year career, he has focused his practice on guiding clients through government reimbursement processes, advocating with federal and state health agencies, and achieving creative solutions to coverage, coding, reimbursement, payment and compliance matters. He also advises investors, financial institutions and companies on regulatory issues involved in mergers and acquisitions, capital markets transactions, and financings.

“We are thrilled to welcome Eric to our growing life sciences and healthcare regulatory group,” said Sonia Nath, Cooley partner and chair of the firm’s global life sciences and healthcare regulatory practice. “His wide-ranging healthcare regulatory experience will bolster our team and clients as they navigate a dynamic and evolving regulatory landscape.”

Greig will play a role in the firm’s CooleyREG offering, which provides efficient and comprehensive guidance on current and emerging regulations globally.

“Now more than ever, healthcare and life sciences companies – and the stakeholders invested in their success – need to understand how the changing government and regulatory landscape impacts their ability to deliver positive outcomes for patients,” said Greig. “I am excited to work with the incredible Cooley team to support their innovative clients through the challenges and opportunities in today’s market.”

Cooley’s top-tier life sciences and healthcare regulatory, corporate, and litigation lawyers have extensive US and global experience counseling on a vast scope of complex deals, regulatory issues and investigations. The firm has represented top global life sciences companies for 40+ years and advises entities across the life sciences landscape. Cooley is consistently ranked as a market leader in the field by Law360, LMG Life Sciences, Chambers and The Legal 500, among others. Most recently, Cooley was named Law360’s Life Sciences Practice Group of the Year, and LMG Life Sciences has recognized the firm in consecutive years in the US and UK.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.